{"id":50408,"date":"2022-11-02T20:03:09","date_gmt":"2022-11-02T19:03:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/"},"modified":"2022-11-02T20:03:09","modified_gmt":"2022-11-02T19:03:09","slug":"solesis-acquires-polyzen-expanding-film-and-coating-capabilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/","title":{"rendered":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities"},"content":{"rendered":"
\n

APEX, N.C.–(BUSINESS WIRE)–#Polyzen<\/a>–Polyzen, LLC, announced today that it has been acquired by Solesis, an advanced biomaterials company that develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, and life sciences industries. Solesis is headquartered in Telford, PA, with manufacturing facilities in Pennsylvania and North Carolina.\n<\/p>\n

\n\u201cThe acquisition creates meaningful value and opportunity for Polyzen and Solesis\u2019 shared customer base. By combining Polyzen\u2019s polymer science experience in film and coating technologies with Solesis\u2019 market leadership in advanced biomaterials, we can accelerate the development of life sciences solutions to address key challenges faced by our medical device and bioprocessing customers,\u201d commented Nikin and Rubin Shah, Co-CEOs of Polyzen.\n<\/p>\n

\n\u201cWe are thrilled about what this new partnership will mean for our customers going forward,\u201d said Karen West, CEO of Solesis. \u201cPolyzen enhances Solesis\u2019 breadth of polymer-based technologies, know-how, and capabilities, all of which will enable us to continue to deliver innovative solutions to our customers.\u201d\n<\/p>\n

\nBased in Apex, NC, Polyzen will operate as a subsidiary of Solesis.\n<\/p>\n

\nPolyzen was advised by Piper Sandler & Co. and Bagchi Law. Cleary Gottlieb acted as legal counsel to Solesis.\n<\/p>\n

\nAbout Polyzen<\/b>\n<\/p>\n

\nPolyzen, LLC, is a leading contract developer and manufacturer of custom medical-grade polymer components and products for the medical device and specialty industrial markets worldwide. With fully equipped facilities in Apex, NC, Polyzen develops concepts from prototype to full-scale production with a variety of technologies and services to meet demanding application and regulatory challenges. Polyzen\u2019s 75,000 sq. ft. facility is fully certified to ISO 9001:2015 and ISO 13485:2016 standards and equipped to handle medical-grade polymer development, processing, and manufacturing. For additional information, please visit our website: www.polyzen.com<\/a>.\n<\/p>\n

\nAbout Solesis<\/b>\n<\/p>\n

\nSolesis is a market leader specializing in biomaterials for the life sciences industry. Operating through its subsidiaries \u2014 Secant Group<\/a> and Charter Medical<\/a> \u2014 Solesis develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, life sciences, and cell and gene therapy industries. Solesis also innovates on behalf of its customers, including through Secant Group\u2019s patented polymer platform poly(glycerol sebacate) (PGS), which demonstrates unparalleled benefits over traditional polymers currently used for drug delivery and medical device applications. Headquartered in Telford, PA, Solesis employs 360 people across four production facilities located in Pennsylvania and North Carolina. For additional information, please visit our website: www.solesis.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSolesis: Jason Mosheim, jason.mosheim@secant.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

APEX, N.C.–(BUSINESS WIRE)–#Polyzen–Polyzen, LLC, announced today that it has been acquired by Solesis, an advanced biomaterials company that develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, and life sciences industries. Solesis is headquartered in Telford, PA, with manufacturing facilities in Pennsylvania and North Carolina. \u201cThe acquisition creates meaningful … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50408","6":"format-standard","7":"category-industry"},"yoast_head":"\nSolesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"APEX, N.C.–(BUSINESS WIRE)–#Polyzen–Polyzen, LLC, announced today that it has been acquired by Solesis, an advanced biomaterials company that develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, and life sciences industries. Solesis is headquartered in Telford, PA, with manufacturing facilities in Pennsylvania and North Carolina. \u201cThe acquisition creates meaningful ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-02T19:03:09+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities\",\"datePublished\":\"2022-11-02T19:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/\"},\"wordCount\":411,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/\",\"name\":\"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-11-02T19:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend","og_description":"APEX, N.C.–(BUSINESS WIRE)–#Polyzen–Polyzen, LLC, announced today that it has been acquired by Solesis, an advanced biomaterials company that develops, manufactures, and sells critical components and technologies for customers in the medical device, biopharmaceutical, and life sciences industries. Solesis is headquartered in Telford, PA, with manufacturing facilities in Pennsylvania and North Carolina. \u201cThe acquisition creates meaningful ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-02T19:03:09+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities","datePublished":"2022-11-02T19:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/"},"wordCount":411,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/","url":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/","name":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-11-02T19:03:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/solesis-acquires-polyzen-expanding-film-and-coating-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Solesis Acquires Polyzen, Expanding Film and Coating Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50408"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50408\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}